I-Win 200 Capsule contains Itraconazole 200 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. I-Win 200 Capsule is typically administered orally and should be taken with food to enhance absorption. The dosage and duration of therapy depend on the type and severity of the infection, as well as patient-specific factors such as age, hepatic function, and concomitant medications. Common adverse effects may include gastrointestinal disturbances, headache, dizziness, and elevated liver enzymes. Caution is advised in patients with hepatic impairment or congestive heart failure. Itraconazole has significant drug interactions due to its inhibition of cytochrome P450 enzymes, necessitating careful review of concurrent medications. Regular monitoring of liver function tests and clinical response is recommended during therapy. I-Win 200 Capsule should be used under medical supervision to ensure efficacy and minimize potential risks.